Bharat biotech biotech, Biotechnology company

India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready, said government sources.India will have a capacity of more than 30 crores by next year per month, which includes Covishield, Covaxin, ZyCoV-D and Biological E, sources told ANI.According to the sources, the production of 60 lakh doses of Zydus Cadila's ZyCoV-D are already ready with the company and Biological E will be submitting the data till November end of phase -3 trials. The Biological E is the third Indian company to make Covid-19 vaccines. The company has also started stockpile doses.Biological E will be providing 30 crore doses and another company that is expected to provide doses is Gennova which is the fourth Indian company doing trials of mRNA vaccines. India is expected to get Gennova's mRNA vaccine doses by February.Earlier, on September 2, NITI Aayog Member (Health) VK Paul had said that the Hyderabad-based pharmaceutical company, Biological E, is expected to launch its vaccine against coronavirus in October this year.Paul had toldthat Phase 3 of Biological E's trial is underway. "Stockpile is being produced. We should wait for the results. We hope it'll be in the next month or two. They've made a broad commitment that they'll supply a significant amount by year-end."India procured more than 26 crore doses in the month of September also.Centre plans to achieve 100 crore doses in next week.Earlier, it was expected to reach the target between October 10 to October 12. The delay and decline in Covid vaccination are due to the festival season and hesitation in the second dose.India may accelerate the export of Covid-19 vaccines under its humanitarian initiative 'Vaccine Maitri' by December after having an excess number of doses in the country.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Marathi Language Controversy

Maharashtra News

Mumbai Local

Weather Update

Mumbai Rains

Ahmedabad Plane Crash

Bharat Biotech BiotechFOLLOW

Bharat biotech biotech, Latest News

National :Bharat Biotech proud to of contribution to historic landmark: Dr Krishna Ella on COVID vaccination coverage crossing 100 cr mark

As India on Thursday crossed 100 crore COVID-19 vaccination, Bharat Biotech's Chairman and Managing Director Dr Krishna Ella said that the firm is proud to have contributed to this 'historic landmark'. ...

National :Administration of ZyCoV-D vaccine requires special training; awaiting NTAGI's final advice: Dr VK Paul

Zydus Cadila's vaccine - ZyCoV-D is the first indigenously manufactured needle-free Covid-19 vaccine which is approved for children aged above 12 for emergency use in the country. Earlier, the Subject Experts Committee (SEC) has also recommended the ...

International :Expecting 'one' additional information on Covaxin, decision on emergency use listing after complete assessment: WHO

World Health Organisation (WHO), which is reviewing the data provided by Bharat Biotech for Emergency Use Listing of COVID-19 vaccine Covaxin, said on Monday that it is "expecting one additional piece of information from the company today". ...

International :WHO's advisory group to meet on Oct 26 to consider Covaxin's emergency usage

Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO's technical advisory group will meet on October 26 to consider emergency use listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxi ...

National :India to procure over 30 crore COVID-19 vaccine doses per month by January: Sources

India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready ...